Korie Osborn

Korie Osborn is an experienced regulatory affairs executive currently serving as the Vice President of Regulatory Affairs at Rosemont Pharmaceuticals since April 2025, where responsibilities include leading regulatory activities for U.S. products, developing regulatory strategies, and negotiating with agencies. Prior roles include Vice President of Regulatory Affairs at Azurity Pharmaceuticals, where Korie developed regulatory strategies and oversaw submissions, and Director of Regulatory Affairs, focusing on document preparation and agency interactions. Experience also encompasses positions at Silvergate Pharmaceuticals as Director of Quality Assurance, Cardinal Health Regulatory Sciences as Senior Scientist, and various quality assurance roles at Acceleration Laboratory Services. Korie holds an MBA from Baker University and a BS in Biology and Chemistry from the University of Central Missouri.